SCA
BPMC

Secor Capital Advisors’s Blueprint Medicines BPMC Stock Holding History

Secor Capital Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-15,076
Closed -$603K – 467
2017
Q1 		$603K Sell
15,076
-13,205
-47% -$473K 0.07% 314
2016
Q4 		$793K Buy
+28,281
New +$852K 0.1% 271

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Secor Capital Advisors's BPMC Position: Q2 2017 in Review

Secor Capital Advisors sold out of Blueprint Medicines (BPMC) in Q2 2017, closing a stake of 15,076 shares — an estimated $603K sold.

Secor Capital Advisors first reported a position in BPMC in Q4 2016 and held it in 2 quarters. The position peaked at $793K in Q4 2016. 124 funds tracked by Wall St. Rank hold BPMC as of Q2 2017.

  • Secor Capital Advisors reported no remaining Blueprint Medicines position as of Q2 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 15,076 Blueprint Medicines shares in Q2 2017, an estimated $603K.
  • Secor Capital Advisors first reported a position in Blueprint Medicines in Q4 2016 and held it in 2 quarters.
  • Secor Capital Advisors's Blueprint Medicines position peaked at $793K in Q4 2016.
  • 124 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2017.

Based on Secor Capital Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.